MPOX Vaccination Resources
Jump to Topic:
- Updates
- Clinical Guidance and Recommendations
- JYNNEOS (Smallpox/mpox) Vaccine Information
- Intradermal Vaccination Resources
- Other Vaccine Administration Resources
- Vaccine Management and Reporting
- Vaccine and Adverse Reactions Information
- Mpox Disease Information and Educational Resources
- Other Resources
- Archived Communications
Updates
- Commercialization of JYNNEOS occured as of April 1,2024. JYNNEOS product can be purchased for insured patients using the wholesalers and distributors found on the Bavarian Nordic website.
- CDC issued updated Standing Orders for Administering JYNNEOS (Mpox) Vaccine by Subcutaneous Injection to Persons 18 Years of Age and Older.
Clinical Guidance and Recommendations
- Interim Clinical Considerations for Use of JYNNEOS Vaccine for Mpox Prevention in the United States | Mpox | Poxvirus | CDC
- Extension of shelf life for SNS JYNNEOS vaccine stored at 2-8°C (36 46°F)
- Extension of shelf life for commercial lots of JYNNEOS vaccine stored at 2-8°C (36 46°F)
- ACIP Interim Recommendations for Routine Use of Mpos Vaccine in Adults at risk of exposure to mpox (October 2023)
- Administering Vaccines: Dose, Route, Site, and Needle Size (Immunize.org)
- MMWR: Interim Guidance for Prevention and Treatment of mpox is Persons with HIV Infection – United States, August 2022
JYNNEOS (Smallpox/Mpox) Vaccine Information
- FDA Webpage on JYNNEOS
- JYNNEOS Vaccine Fact Sheet | Provider Letter
- JYNNEOS Vaccine Information Statement (VIS) | Spanish (distribute to recipient prior to vaccination)
- JYNNEOS Package Insert (2023)
- JYNNEOS EUA Fact Sheet for Providers (8/2022)
- JYNNEOS EUA Fact Sheet for Recipients and Caregivers (8/2022)
Intradermal Vaccination Resources
- JYNNEOS Intradermal Administration job aid (CDC)
- JYNNEOS Intradermal Administration video (CDC)
- JYNNEOS Preparation and Administration Summary for Intradermal Administration (CDC)
- JYNNEOS Standing Orders for Intradermal Administration (CDC)
- JYNNEOS Intradermal Vaccination: Patient Counseling (CDC)
- JYNNEOS Intradermal Vaccination Considerations for Specific Populations (CDC)
- JYNNEOS EUA Fact Sheet for Providers (8/2022)
- JYNNEOS EUA Fact Sheet for Recipients and Caregivers (8/2022)
- CDC/FDA COCA Call: Interim Clinical Considerations for Mpox Vaccination (slides, 8/2022)
Other Vaccine Administration Resources
- Standing Orders for Administering JYNNEOS (Mpox) Vaccine by Subcutaneous Injection to Persons 18 Years of Age and Older. (CDC)
- Subcutaneous Injection video (CDC)
- Preparing Liquid Vaccines
- Administering Injections
Vaccine Management and Reporting
- Mpox Ordering & Distribution Cadence Calendar
- Mpox Requirements at a Glance
- JYNNEOS Storage & Handling Summary (CDC)
- Instructions for Flipping Off Cap for MVA-BN
- General Vaccine Storage and Handling job aids
- California Immunization Record:
Blank for Computer Print Out | Vaccines Listed to Fill Out by Hand
Vaccine and Adverse Reactions Information
- JYNNEOS Vaccine Administration Errors and Deviations (CDC)
- JYNNEOS Contraindications & Precautions (CDC)
- Vaccine Adverse Event Reporting System (VAERS)
- Office Management of Anaphylaxis (CDPH)
- VAERS and VERP flyer (CDPH)
Mpox Disease Information and Educational Resources
- California Primary Care Association (CPCA) Mpox Webinar, 8/23/22 Slides and Recording
- Mpox Communications Toolkit (CDPH)
- US Mpox Outbreak 2022: Situational Summary (CDC)
- Mpox Information for Healthcare Professionals (CDC)
- Interim Clinical Guidance for Treatment of Mpox (CDC)
- Orthopoxvirus and Mpox Coding & Guidance (AMA)
- HRSA Countermeasures Injury Compensation Program (CICP)
Archived messages from CDPH can be found on our EZIZ mainpage under the tab ‘From CDPH’